FAKTOR-OPTIONSSCHEIN - AMGEN Share Price

DE000SB01SZ2

Market Closed - Boerse Frankfurt Warrants 01:20:45 22/06/2024 am IST
0.16 ^EUR	+6.67%

Current month	+14.29%
1 month	-20.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

US FDA approves Roche's drug for a chronic blood disorder	22/06	RE
Amgen : Bringing Cardiovascular Care to the Heart of Communities	21/06	PU
Amgen : Continues to Propel BiTE® Technology Innovation	20/06	PU
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto	15/06	DJ

More news

Quotes 5-day view

Date	Price	Change
21/24/21	0.16	+6.67%
20/24/20	0.15	+7.14%
19/24/19	0.14	0.00%
18/24/18	0.14	+7.69%
17/24/17	0.13	+8.33%

Real-time Boerse Frankfurt Warrants

Last update June 22, 2024 at 01:20 am IST

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Société Générale
WKN	SB01SZ
ISIN	DE000SB01SZ2
Date issued	09/06/2020
Strike	225.4 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.82 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	22.88 €
Lowest since issue	0.052 €
Spread	0.01 €
Spread %	6.25%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

308.2 USD

Average target price

316.4 USD

Spread / Average Target

+2.69%

Consensus